Pola Orbis Holdings (4927) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
13 May, 2026Executive summary
Consolidated net sales rose 1.0% year-over-year to ¥41,313 million in Q1 FY2025, driven by ORBIS brand growth and domestic market recovery.
Operating income increased 23.5% year-over-year to ¥4,148 million, mainly due to higher gross profit from increased sales.
Profit attributable to owners of parent fell 58.1% year-over-year to ¥1,310 million, mainly due to a swing from foreign exchange gains to losses.
Ordinary income declined 47.1% year-over-year to ¥2,470 million, impacted by foreign exchange losses.
The Japanese cosmetics market remained stable with inbound demand, while the Chinese market showed signs of recovery but with uncertain consumption trends.
Financial highlights
Gross profit increased 1.5% year-over-year to ¥34,042 million, with the cost of sales ratio improving from 18.0% to 17.6%.
SG&A expenses decreased 0.9% year-over-year to ¥29,894 million, supporting higher operating margins (10.0% vs. 8.2% last year).
Net assets per share at the end of Q1 FY2025 were ¥721.83, down from ¥744.16 at the end of FY2024.
Comprehensive income for Q1 FY2025 was ¥1,921 million, down 30.9% year-over-year.
Ordinary income dropped 47.1% year-over-year to ¥2,470 million due to foreign exchange losses.
Outlook and guidance
FY2025 full-year guidance is unchanged: consolidated net sales of ¥174,000 million (+2.1% year-over-year), operating income of ¥14,500 million (+5.0%), and profit attributable to owners of parent of ¥8,500 million (-8.5%).
Dividend forecast maintained at ¥52 per share (payout ratio 135.4%).
No revisions to previously announced forecasts.
Latest events from Pola Orbis Holdings
- Operating income rose 12.3% on cost cuts, but FX losses drove profit down 38.1%.4927
Q2 202513 May 2026 - Net sales and income fell, but profit rose on forex gains; full-year outlook trimmed.4927
Q2 202413 May 2026 - Operating profit up 18.7% and profit attributable to owners up 88.0% despite lower sales.4927
Q1 202613 May 2026 - Sales and profits fell, but domestic growth and ORBIS strength kept full-year outlook steady.4927
Q3 202413 May 2026 - Sales and profits fell in FY2024, but ORBIS grew and FY2025 targets modest recovery.4927
Q4 202413 May 2026 - Operating income rose 10.5% year-over-year despite flat sales, led by ORBIS and cost controls.4927
Q3 202513 May 2026 - Operating income rose 13.6% on flat sales; FY2026 profit to fall due to restructuring costs.4927
Q4 202513 May 2026